March 6, 2026
Women treated with GLP-1 for weight loss show significantly higher rates of weight loss compared with men, but notably, no significant differences are observed in a […]
March 6, 2026
TOPLINE: Children who presented with perianal abscess or fistula-in-ano faced an age-dependent increased risk of developing Crohn’s disease (CD); over 1 in 5 children were diagnosed […]
March 6, 2026
TOPLINE: Multimodal profiling — combining autonomic testing, body surface gastric mapping (BSGM), and gastric emptying — revealed autonomic dysfunction in patients with chronic gastroduodenal symptoms. Autonomic […]
March 5, 2026
Three obesity associations have issued the latest guidance on pharmacologic treatment of obesity, based on the published evidence to date for all medications currently available in […]
March 5, 2026
Gens X, Y and Z may each be profitable target markets, but when it comes to grocery store sales, companies are tailoring products to the next […]
March 5, 2026
TOPLINE: Among patients who were eligible for metabolic and bariatric surgery in a national sample in the US, prescriptions for semaglutide and tirzepatide increased dramatically from […]
March 5, 2026
* Through the Lilly Employer Connect platform, itsmulti-dose weight-loss drug device Zepbound KwikPen will beavailable to network pharmacies at a discounted price of $449for all doses […]
March 5, 2026
TOPLINE: Researchers developed and validated a machine learning model based on logistic regression that used routine clinical and treatment data to accurately predict in-hospital deaths among […]
March 4, 2026
TOPLINE: A notable proportion of older adults with inflammatory bowel disease (IBD) screened positive for cognitive impairment at baseline in this longitudinal cohort study. Symptomatically active […]